S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

LLY Eli Lilly and Co

774.79

-1.96 (-0.25%)

Pre Market

Last Updated: 22:09:08

Delayed by 15 minutes

Lilly picks internal candidate for CFO position

To read the full story on Seeking Alpha, click here.

Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Eli Lilly Charts.

Eli Lilly (NYSE:LLY)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Eli Lilly Charts.

Eli Lilly and Co News

Futures Pointing To Roughly Flat Open On Wall Street
Tuesday 30 April 2024 (2 days ago) • IH Market News

U.S. Index Futures Point to Mild Decline Ahead of Key Earnings and Fed Rate Decision
Tuesday 30 April 2024 (2 days ago) • IH Market News

HSBC’s High Profit & CEO Resignation, Santander’s 11% Profit Surge, and More in Earnings
Tuesday 30 April 2024 (2 days ago) • IH Market News

Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
Tuesday 30 April 2024 (2 days ago) • PR Newswire (US)

Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity
Wednesday 17 April 2024 (2 weeks ago) • PR Newswire (US)

Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement
Wednesday 17 April 2024 (2 weeks ago) • PR Newswire (US)

Cal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and More
Wednesday 3 April 2024 (4 weeks ago) • IH Market News

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)

More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab study
Monday 11 March 2024 (2 months ago) • PR Newswire (US)

U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab
Friday 8 March 2024 (2 months ago) • PR Newswire (US)

Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity Care
Friday 8 March 2024 (2 months ago) • PR Newswire (US)

More Eli Lilly and Co News Articles

Commonwealth Bank Of Aus...

Newcrest Mining

National Australia Bank

AUD vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions